Join the AUA for Non-Muscle Invasive Bladder Cancer: Expert Guidance for Urologists and Advanced Practice Providers featuring three dynamic webinars – two tailored specifically for Urologists and presented in English and Español and another for Advanced Practice Providers (APPs) presented in English. Each course showcases an expert multidisciplinary panel ready to dive into an engaging discussion on the latest breakthroughs and strategies in NMIBC management. Don’t miss this chance to elevate your expertise in this critical field.
Cáncer de Vejiga No Invasivo Muscular: Orientación de Expertos Para Urólogos - Español (2024)
Non-Muscle Invasive Bladder Cancer: Expert Guidance for Advanced Practice Providers (2024)
Non-Muscle Invasive Bladder Cancer: Expert Guidance for Urologists - English (2024)
AUAUniversity Podcast: Non-Muscle Invasive Bladder Cancer: Expert Guidance for Urologists - English (2024)
This educational activity is supported by independent educational grants from ImmunityBio, Inc., Merck & Co., Inc. and UroGen Pharma, Inc.
ACCREDITATION:
The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION:
The American Urological Association designates these enduring materials for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
OTHER LEARNERS:
The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.
